1 – 6 of 6
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance
(
- Contribution to journal › Article
- 2018
-
Mark
The Movember Foundation's GAP3 cohort : a profile of the largest global prostate cancer active surveillance database to date
(
- Contribution to journal › Article
- 2016
-
Mark
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
(
- Contribution to journal › Article
- 2014
-
Mark
The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men.
(
- Contribution to journal › Article
- 2013
-
Mark
Predictive Value of Four Kallikrein Markers for Pathologically Insignificant Compared With Aggressive Prostate Cancer in Radical Prostatectomy Specimens: Results From the European Randomized Study of Screening for Prostate Cancer Section Rotterdam
(
- Contribution to journal › Article
- 2012
-
Mark
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators : Results from the prostate biopsy collaborative group
(
- Contribution to journal › Article